A randomized, open-label study of the effect of CellCept on the pharmacokinetics of tacrolimus and clinical outcome in liver transplant patients.
Phase of Trial: Phase II
Latest Information Update: 26 Feb 2010
At a glance
- Drugs Mycophenolate mofetil (Primary) ; Tacrolimus
- Indications Liver transplant rejection
- Focus Pharmacokinetics; Therapeutic Use
- 26 Feb 2010 New trial record